These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2041274

  • 1. [Transurethral intracavitary irradiation for carcinoma of the prostate].
    Kigure T, Harada T, Nishizawa O, Miyagata S, Koh D, Shimoda J, Yoshida K, Satoh Y, Tsukada T, Tsuchida S.
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):305-11. PubMed ID: 2041274
    [Abstract] [Full Text] [Related]

  • 2. Local control of prostate cancer with transurethral intracavitary radiation therapy.
    Harada T, Kigure T, Yuri Y, Tsuchida S, Kato T, Watarai J, Saito K.
    Radiat Med; 1993 Feb; 11(4):139-45. PubMed ID: 8234857
    [Abstract] [Full Text] [Related]

  • 3. Transurethral 137Cs medium dose rate radiotherapy as a boost for small-sized localized prostatic carcinomas.
    Skarlatos J, Koukourakis M, Zambatis H, Varveris C, Karvelas S, Tsopelas N, Yannakakis D.
    Urol Int; 1994 Feb; 53(4):209-13. PubMed ID: 7855938
    [Abstract] [Full Text] [Related]

  • 4. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.
    Stromberg J, Martinez A, Gonzalez J, Edmundson G, Ohanian N, Vicini F, Hollander J, Gustafson G, Spencer W, Yan Di.
    Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):161-71. PubMed ID: 7543891
    [Abstract] [Full Text] [Related]

  • 5. High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial.
    Dinges S, Deger S, Koswig S, Boehmer D, Schnorr D, Wiegel T, Loening SA, Dietel M, Hinkelbein W, Budach V.
    Radiother Oncol; 1998 Aug 30; 48(2):197-202. PubMed ID: 9783892
    [Abstract] [Full Text] [Related]

  • 6. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.
    Martinez A, Gonzalez J, Stromberg J, Edmundson G, Plunkett M, Gustafson G, Brown D, Yan D, Vicini F, Brabbins D.
    Int J Radiat Oncol Biol Phys; 1995 Dec 01; 33(5):1019-27. PubMed ID: 7493828
    [Abstract] [Full Text] [Related]

  • 7. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
    Stromberg J, Martinez A, Benson R, Garton G, Diokno A, Gonzalez J, Zincke H, Schray M, Edmundson G, Brabbins D.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):67-75. PubMed ID: 8270460
    [Abstract] [Full Text] [Related]

  • 8. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG, Stone NN, DeWyngaert JK, Lavagnini P, Unger PD.
    Cancer; 1996 Jun 01; 77(11):2386-92. PubMed ID: 8635111
    [Abstract] [Full Text] [Related]

  • 9. The dosimetry of prostate brachytherapy-induced urethral strictures.
    Merrick GS, Butler WM, Tollenaar BG, Galbreath RW, Lief JH.
    Int J Radiat Oncol Biol Phys; 2002 Feb 01; 52(2):461-8. PubMed ID: 11872293
    [Abstract] [Full Text] [Related]

  • 10. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.
    Martin T, Baltas D, Kurek R, Röddiger S, Kontova M, Anagnostopoulos G, Dannenberg T, Buhleier T, Skazikis G, Tunn U, Zamboglou N.
    Strahlenther Onkol; 2004 Apr 01; 180(4):225-32. PubMed ID: 15057433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 15. [Brachytherapy boost irradiation in the treatment of high risk, localised prostate cancer. Initial national experience in Hungary].
    Agoston P, Major T, Somogyi A, Szûcs M, Danczig A, Lövey J, Polgár C, Fodor J, Németh G, Kásler M.
    Magy Onkol; 2004 Oct 01; 48(1):81-8. PubMed ID: 15105901
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K, Yoshioka Y, Isohashi F, Sumida I, Kawaguchi Y, Kotsuma T, Adachi K, Morimoto M, Fukuda S, Inoue T.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1003-7. PubMed ID: 19345517
    [Abstract] [Full Text] [Related]

  • 18. Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancer.
    Gómez-Iturriaga Piña A, Crook J, Borg J, Lockwood G, Fleshner N.
    Urology; 2010 Jun 15; 75(6):1412-6. PubMed ID: 20035986
    [Abstract] [Full Text] [Related]

  • 19. High dose rate transurethral brachytherapy as a boost dose for localized adenocarcinoma of the prostate.
    Serin M, Erkal HS, Sak SD, Cakmak A, Göğüş O, Akkaya A.
    Urol Int; 1997 Jun 15; 58(1):30-3. PubMed ID: 9058517
    [Abstract] [Full Text] [Related]

  • 20. Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.
    Rose JN, Crook JM, Pickles T, Keyes M, Morris WJ.
    Brachytherapy; 2015 Jun 15; 14(3):342-9. PubMed ID: 25727178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.